ClinicalTrials.gov
public full text
Public Domain
Pharmacokinetics of Inhaled Levosimendan
Determination of biological availability, time-to-peak and elimination half-life of inhaled levosimendan by administration of an inhaled- and intravenous dose of levosimendan.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients#833229
- Levosimendan In Ambulatory Heart Failure Patients#801324
- Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics#841459
- The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement#864981
- LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF#314415
Record · ID 1111749
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive